Joint R&D Agreement*Joint R&d Agreement • April 18th, 2005 • American Oriental Bioengineering Inc • Pharmaceutical preparations
Both parties agree to the following content after friendly discussion, in conformity with related laws and regulations of PRC:
Joint R&D with PeptiDream Inc.Joint R&d Agreement • March 25th, 2016
Asahi Kasei Pharma Corp. (Head office: Chiyoda-ku, Tokyo, Japan; President: Kazuyoshi Hori) and PeptiDream Inc. (Head office: Meguro-ku, Tokyo, Japan; CEO: Kiichi Kubota) have concluded a joint R&D agreement for the discovery and development of nonstandard peptides1 against multiple drug target molecules.
